Multiple Australian outlets report findings from an Australian study suggesting melatonin could be beneficial for people living with chronic pain. The coverage is consistent in stating that researchers examined melatonin’s effects in individuals with chronic pain and found it associated with improvements in pain outcomes compared with baseline or control conditions used in the study design. While the articles do not provide detailed methodology, dosing, or the size of effects in the excerpts provided, they converge on the central message: melatonin may offer a potential additional option for managing chronic pain. The reports also frame the findings as supportive of melatonin’s role in this context, rather than a replacement for existing care. Across sources, the tone remains factual and centered on the results of the Australian research, with no outlet identified as challenging or contradicting the basic conclusion. Further details such as participant numbers, duration of treatment, and statistical outcomes are not included in the supplied summaries.